<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01107834</url>
  </required_header>
  <id_info>
    <org_study_id>10-0121</org_study_id>
    <nct_id>NCT01107834</nct_id>
  </id_info>
  <brief_title>Heart Function in HIV-Negative Children Exposed to HIV and HAART</brief_title>
  <official_title>Left Ventricular Function in HIV-Negative Children Exposed to HIV and HAART In Utero</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Washington University School of Medicine</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>GlaxoSmithKline</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Washington University School of Medicine</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      HIV-uninfected children born to HIV+ women have low level heart problems at birth which may
      predispose them to heart failure, arrythmias and heart attack later in life. The impact of
      these heart problems on future heart health is unclear as it is unknown if heart problems in
      these children persist, worsen or resolve in pre-pubescence. The objective of this study is
      to characterize heart function in HIV-negative pre-pubertal children born to HIV+ women and
      exposed to HIV and HAART in utero and compare them to age and gender matched healthy children
      born to HIV-negative women. Through this objective we will determine if heart problems in
      HIV-negative children born to HIV+ women and exposed to HAART in utero persists, worsens, or
      resolves during pre-pubescence.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Significance:

      Approximately 700,000 children annually are born to HIV-infected mothers throughout the
      world, but with the advent of perinatal highly active antiretroviral therapy (HAART), the
      majority of children are born uninfected in Westernized nations and those uninfected are
      increasing in developing nations. Uninfected children exposed to HIV and HAART in utero, have
      subclinical left ventricular dysfunction (LVD) at birth which may predispose them to heart
      failure, conduction abnormalities and myocardial infarction later in life. The impact of this
      LVD on future cardiac risk is unclear as it is unknown if LVD in these children persist,
      worsen or resolve in pre-pubescence.

      Study objectives:

      The objective of this study is to characterize left ventricular function in HIV-negative
      pre-pubertal children born to HIV+ women and exposed to HIV and HAART in utero and compare
      them to age and gender matched healthy children born to HIV-negative women. Through this
      objective we will determine if LVD in HIV-negative children born to HIV+ women and exposed to
      HAART in utero persists, worsens, or resolves during pre-pubescence. If LVD persists or
      worsens in pre-pubescence, these data will lead to future studies examining mechanisms of and
      treatments for LVD in these children and will significantly impact the clinical monitoring
      and care of these children. If LVD resolves during pre-pubescence, then these data will
      provide important information that clinical cardiac monitoring may not be critical in this
      population.

      Methods:

      We plan to examine left ventricular function in 30 HIV-negative children born to HIV+ women
      and exposed to HAART in utero and compare them to 30 healthy age and gender matched children
      born to HIV-negative women. Left ventricular function will be examined by 2-D, Doppler and
      Tissue Doppler imaging echocardiography using a General Electric Vivid 7Â® ultrasound machine.
      Left ventricular measures will include left ventricular structure and dimensions, systolic
      and diastolic flow rates, wall velocities during systole and diastole and systolic and
      diastolic strain and strain rates (sensitive measures of myocardial contractility).
      Echocardiographic measures will take place in the Cardiovascular Imaging Laboratory (CVIL) at
      Washington University School of Medicine by a certified cardiac ultrasonographer and data
      will be processed, analyzed and interpreted by the ultrasonographer, a consulting
      cardiologist and the principal investigator.

      Outcomes:

      Primary outcomes will include measures of left ventricular function: left ventricular mass,
      left ventricular end diastolic dimension, fractional shortening, systolic and diastolic wall
      velocities (tissue Doppler imaging) and systolic and diastolic strain and strain rates (2-D
      speckle tracking methodology).
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>May 2010</start_date>
  <completion_date type="Actual">December 2011</completion_date>
  <primary_completion_date type="Actual">December 2011</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case Control</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Left Ventricular Mass Index</measure>
    <time_frame>Baseline</time_frame>
    <description>left ventricular mass index measured by 2D echocardiography</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Fractional Shortening</measure>
    <time_frame>Baseline</time_frame>
    <description>Fractional shortening measured by M-mode cardiography</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Global Strain Rate</measure>
    <time_frame>Baseline</time_frame>
    <description>Myocardial deformation (a measure of heart contractility) measured by speckel tracking echocardiography</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Systolic Myocardial Velocity During Systole (S')</measure>
    <time_frame>Baseline</time_frame>
    <description>Systolic myocardial velocity during systole measured by tissue Doppler echocardiography</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Early to Late Diastolic Filling Ratio</measure>
    <time_frame>Baseline</time_frame>
    <description>Early to late diastolic filling ratio measured by tissue Doppler echocardiography</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Myocardial Wall Velocity During Early Diastole</measure>
    <time_frame>Baseline</time_frame>
    <description>Myocardial wall velocity during early diastolemeasured by tissue Doppler imaging</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">60</enrollment>
  <condition>HIV Infections</condition>
  <arm_group>
    <arm_group_label>Healthy Control</arm_group_label>
    <description>HIV-negative children born to healthy, HIV-negative women</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Exposed to HIV/HAART</arm_group_label>
    <description>HIV-negative children exposed to HIV and HAART in utero</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        HIV-negative children will be recruited through their HIV+ mothers who are seen at the AIDS
        Clinical Trials Unit at Washington University and surrounding St. Louis community clinics.
        HIV-negative children will be recruit through Washington University and surrounding St.
        Louis pediatric clinics, and through Washington University Volunteers for Health service.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Age 5-12 years

          2. Tanner stage I-III

          3. Born to HIV+ mother

          4. No HIV infection

          5. Had taken standard of care prophylactic HAART at birth-1 month of age

          6. Child currently not taking medications or have medical diagnosis that would affect
             left ventricular function

          7. Mother was taking HAART during pregnancy (standard of care)

          8. Mother was not using illegal drugs during pregnancy

          9. No intrauterine growth restriction diagnosis during pregnancy

         10. During pregnancy, mother will not have a diagnosis of type 2 diabetes or gestational
             diabetes.

        Exclusion Criteria:

          1. Age 5-12 years

          2. Tanner stage I-III

          3. Born to HIV-negative mother

          4. Mother was not a frequent exerciser during pregnancy (&gt;2x/week)

          5. Mother will not have gestational diabetes or a diagnosis of type 2 diabetes during
             pregnancy of the child being studied

          6. Child currently not taking medications or have medical diagnosis that would affect
             left ventricular function
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>5 Years</minimum_age>
    <maximum_age>12 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>William T Cade, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Washington University School of Medicine</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Washington University School of Medicine</name>
      <address>
        <city>St. Louis</city>
        <state>Missouri</state>
        <zip>63110</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <results_reference>
    <citation>Cade WT, Waggoner AD, Hubert S, Krauss MJ, Singh GK, Overton ET. Reduced diastolic function and left ventricular mass in HIV-negative preadolescent children exposed to antiretroviral therapy in utero. AIDS. 2012 Oct 23;26(16):2053-8. doi: 10.1097/QAD.0b013e328358d4d7.</citation>
    <PMID>22874520</PMID>
  </results_reference>
  <verification_date>June 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 19, 2010</study_first_submitted>
  <study_first_submitted_qc>April 19, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 21, 2010</study_first_posted>
  <results_first_submitted>December 16, 2013</results_first_submitted>
  <results_first_submitted_qc>June 8, 2016</results_first_submitted_qc>
  <results_first_posted type="Estimate">July 20, 2016</results_first_posted>
  <last_update_submitted>June 8, 2016</last_update_submitted>
  <last_update_submitted_qc>June 8, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 20, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Washington University School of Medicine</investigator_affiliation>
    <investigator_full_name>W. Todd Cade</investigator_full_name>
    <investigator_title>Assistant Professor of Physical Therapy and Medicine</investigator_title>
  </responsible_party>
  <keyword>HIV</keyword>
  <keyword>heart function</keyword>
  <keyword>HAART</keyword>
  <keyword>in utero</keyword>
  <keyword>children</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>HIV Infections</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Healthy Control</title>
          <description>HIV-negative children born to healthy, HIV-negative women</description>
        </group>
        <group group_id="P2">
          <title>Exposed to HIV/HAART</title>
          <description>HIV-negative children exposed to HIV and HAART in utero</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="30"/>
                <participants group_id="P2" count="30"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="30"/>
                <participants group_id="P2" count="30"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Healthy Control</title>
          <description>HIV-negative children born to healthy, HIV-negative women</description>
        </group>
        <group group_id="B2">
          <title>Exposed to HIV/HAART</title>
          <description>HIV-negative children exposed to HIV and HAART in utero</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="30"/>
            <count group_id="B2" value="30"/>
            <count group_id="B3" value="60"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="8" spread="2"/>
                    <measurement group_id="B2" value="8" spread="3"/>
                    <measurement group_id="B3" value="8" spread="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="11"/>
                    <measurement group_id="B2" value="11"/>
                    <measurement group_id="B3" value="22"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="19"/>
                    <measurement group_id="B2" value="19"/>
                    <measurement group_id="B3" value="38"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>American Indian or Alaska Native</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Asian</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Native Hawaiian or Other Pacific Islander</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Black or African American</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="22"/>
                    <measurement group_id="B2" value="23"/>
                    <measurement group_id="B3" value="45"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>White</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="6"/>
                    <measurement group_id="B2" value="6"/>
                    <measurement group_id="B3" value="12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>More than one race</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Unknown or Not Reported</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="30"/>
                    <measurement group_id="B2" value="30"/>
                    <measurement group_id="B3" value="60"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Left Ventricular Mass Index</title>
        <description>left ventricular mass index measured by 2D echocardiography</description>
        <time_frame>Baseline</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Healthy Control</title>
            <description>HIV-negative children born to healthy, HIV-negative women</description>
          </group>
          <group group_id="O2">
            <title>Exposed to HIV/HAART</title>
            <description>HIV-negative children exposed to HIV and HAART in utero</description>
          </group>
        </group_list>
        <measure>
          <title>Left Ventricular Mass Index</title>
          <description>left ventricular mass index measured by 2D echocardiography</description>
          <units>g/m2</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="30"/>
                <count group_id="O2" value="30"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="67" spread="12"/>
                    <measurement group_id="O2" value="60" spread="9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>T-test to detect differences between groups</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.27</p_value>
            <method>t-test, 2 sided</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Fractional Shortening</title>
        <description>Fractional shortening measured by M-mode cardiography</description>
        <time_frame>Baseline</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Healthy Control</title>
            <description>HIV-negative children born to healthy, HIV-negative women</description>
          </group>
          <group group_id="O2">
            <title>Exposed to HIV/HAART</title>
            <description>HIV-negative children exposed to HIV and HAART in utero</description>
          </group>
        </group_list>
        <measure>
          <title>Fractional Shortening</title>
          <description>Fractional shortening measured by M-mode cardiography</description>
          <units>percentage of full contraction</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="30"/>
                <count group_id="O2" value="30"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="36" spread="5"/>
                    <measurement group_id="O2" value="37" spread="7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>T-test to detect differences between groups</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.46</p_value>
            <method>t-test, 2 sided</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Global Strain Rate</title>
        <description>Myocardial deformation (a measure of heart contractility) measured by speckel tracking echocardiography</description>
        <time_frame>Baseline</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Healthy Control</title>
            <description>HIV-negative children born to healthy, HIV-negative women</description>
          </group>
          <group group_id="O2">
            <title>Exposed to HIV/HAART</title>
            <description>HIV-negative children exposed to HIV and HAART in utero</description>
          </group>
        </group_list>
        <measure>
          <title>Global Strain Rate</title>
          <description>Myocardial deformation (a measure of heart contractility) measured by speckel tracking echocardiography</description>
          <units>percentage of full deformation</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="30"/>
                <count group_id="O2" value="30"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-22.3" spread="3.2"/>
                    <measurement group_id="O2" value="-21.1" spread="2.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>T-test to detect differences between groups</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.13</p_value>
            <method>t-test, 2 sided</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Systolic Myocardial Velocity During Systole (S')</title>
        <description>Systolic myocardial velocity during systole measured by tissue Doppler echocardiography</description>
        <time_frame>Baseline</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Healthy Control</title>
            <description>HIV-negative children born to healthy, HIV-negative women</description>
          </group>
          <group group_id="O2">
            <title>Exposed to HIV/HAART</title>
            <description>HIV-negative children exposed to HIV and HAART in utero</description>
          </group>
        </group_list>
        <measure>
          <title>Systolic Myocardial Velocity During Systole (S')</title>
          <description>Systolic myocardial velocity during systole measured by tissue Doppler echocardiography</description>
          <units>cm/s</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="30"/>
                <count group_id="O2" value="30"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9.3" spread="1.1"/>
                    <measurement group_id="O2" value="9.1" spread="1.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>T-test to detect differences between groups</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.59</p_value>
            <method>t-test, 2 sided</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Early to Late Diastolic Filling Ratio</title>
        <description>Early to late diastolic filling ratio measured by tissue Doppler echocardiography</description>
        <time_frame>Baseline</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Healthy Control</title>
            <description>HIV-negative children born to healthy, HIV-negative women</description>
          </group>
          <group group_id="O2">
            <title>Exposed to HIV/HAART</title>
            <description>HIV-negative children exposed to HIV and HAART in utero</description>
          </group>
        </group_list>
        <measure>
          <title>Early to Late Diastolic Filling Ratio</title>
          <description>Early to late diastolic filling ratio measured by tissue Doppler echocardiography</description>
          <units>ratio, unitless</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="30"/>
                <count group_id="O2" value="30"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.1" spread="0.5"/>
                    <measurement group_id="O2" value="1.8" spread="0.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>T-test to detect differences between groups</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.09</p_value>
            <method>t-test, 2 sided</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Myocardial Wall Velocity During Early Diastole</title>
        <description>Myocardial wall velocity during early diastolemeasured by tissue Doppler imaging</description>
        <time_frame>Baseline</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Healthy Control</title>
            <description>HIV-negative children born to healthy, HIV-negative women</description>
          </group>
          <group group_id="O2">
            <title>Exposed to HIV/HAART</title>
            <description>HIV-negative children exposed to HIV and HAART in utero</description>
          </group>
        </group_list>
        <measure>
          <title>Myocardial Wall Velocity During Early Diastole</title>
          <description>Myocardial wall velocity during early diastolemeasured by tissue Doppler imaging</description>
          <units>cm/s</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="30"/>
                <count group_id="O2" value="30"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="16.3" spread="2.5"/>
                    <measurement group_id="O2" value="15.0" spread="2.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>T-test to detect differences between groups</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.03</p_value>
            <method>t-test, 2 sided</method>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>1 year</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Healthy Control</title>
          <description>HIV-negative children born to healthy, HIV-negative women
No adverse events</description>
        </group>
        <group group_id="E2">
          <title>Exposed to HIV/HAART</title>
          <description>HIV-negative children exposed to HIV and HAART in utero
No adverse events</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="30"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="30"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>William T. Cade</name_or_title>
      <organization>Washington University</organization>
      <phone>314-286-1432</phone>
      <email>tcade@wustl.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

